Cargando…
CRISPR-Trap: a clean approach for the generation of gene knockouts and gene replacements in human cells
CRISPR/Cas9-based genome editing offers the possibility to knock out almost any gene of interest in an affordable and simple manner. The most common strategy is the introduction of a frameshift into the open reading frame (ORF) of the target gene which truncates the coding sequence (CDS) and targets...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The American Society for Cell Biology
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5909934/ https://www.ncbi.nlm.nih.gov/pubmed/29167381 http://dx.doi.org/10.1091/mbc.E17-05-0288 |
_version_ | 1783315976674082816 |
---|---|
author | Reber, Stefan Mechtersheimer, Jonas Nasif, Sofia Benitez, Julio Aguila Colombo, Martino Domanski, Michal Jutzi, Daniel Hedlund, Eva Ruepp, Marc-David |
author_facet | Reber, Stefan Mechtersheimer, Jonas Nasif, Sofia Benitez, Julio Aguila Colombo, Martino Domanski, Michal Jutzi, Daniel Hedlund, Eva Ruepp, Marc-David |
author_sort | Reber, Stefan |
collection | PubMed |
description | CRISPR/Cas9-based genome editing offers the possibility to knock out almost any gene of interest in an affordable and simple manner. The most common strategy is the introduction of a frameshift into the open reading frame (ORF) of the target gene which truncates the coding sequence (CDS) and targets the corresponding transcript for degradation by nonsense-mediated mRNA decay (NMD). However, we show that transcripts containing premature termination codons (PTCs) are not always degraded efficiently and can generate C-terminally truncated proteins which might have residual or dominant negative functions. Therefore, we recommend an alternative approach for knocking out genes, which combines CRISPR/Cas9 with gene traps (CRISPR-Trap) and is applicable to ∼50% of all spliced human protein-coding genes and a large subset of lncRNAs. CRISPR-Trap completely prevents the expression of the ORF and avoids expression of C-terminal truncated proteins. We demonstrate the feasibility of CRISPR-Trap by utilizing it to knock out several genes in different human cell lines. Finally, we also show that this approach can be used to efficiently generate gene replacements allowing for modulation of protein levels for otherwise lethal knockouts (KOs). Thus, CRISPR-Trap offers several advantages over conventional KO approaches and allows for generation of clean CRISPR/Cas9-based KOs. |
format | Online Article Text |
id | pubmed-5909934 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | The American Society for Cell Biology |
record_format | MEDLINE/PubMed |
spelling | pubmed-59099342018-04-27 CRISPR-Trap: a clean approach for the generation of gene knockouts and gene replacements in human cells Reber, Stefan Mechtersheimer, Jonas Nasif, Sofia Benitez, Julio Aguila Colombo, Martino Domanski, Michal Jutzi, Daniel Hedlund, Eva Ruepp, Marc-David Mol Biol Cell Brief Report CRISPR/Cas9-based genome editing offers the possibility to knock out almost any gene of interest in an affordable and simple manner. The most common strategy is the introduction of a frameshift into the open reading frame (ORF) of the target gene which truncates the coding sequence (CDS) and targets the corresponding transcript for degradation by nonsense-mediated mRNA decay (NMD). However, we show that transcripts containing premature termination codons (PTCs) are not always degraded efficiently and can generate C-terminally truncated proteins which might have residual or dominant negative functions. Therefore, we recommend an alternative approach for knocking out genes, which combines CRISPR/Cas9 with gene traps (CRISPR-Trap) and is applicable to ∼50% of all spliced human protein-coding genes and a large subset of lncRNAs. CRISPR-Trap completely prevents the expression of the ORF and avoids expression of C-terminal truncated proteins. We demonstrate the feasibility of CRISPR-Trap by utilizing it to knock out several genes in different human cell lines. Finally, we also show that this approach can be used to efficiently generate gene replacements allowing for modulation of protein levels for otherwise lethal knockouts (KOs). Thus, CRISPR-Trap offers several advantages over conventional KO approaches and allows for generation of clean CRISPR/Cas9-based KOs. The American Society for Cell Biology 2018-01-15 /pmc/articles/PMC5909934/ /pubmed/29167381 http://dx.doi.org/10.1091/mbc.E17-05-0288 Text en © 2018 Reber, Mechtersheimer, et al. “ASCB®,” “The American Society for Cell Biology®,” and “Molecular Biology of the Cell®” are registered trademarks of The American Society for Cell Biology. http://creativecommons.org/licenses/by-nc-sa/3.0/ This article is distributed by The American Society for Cell Biology under license from the author(s). Two months after publication it is available to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported Creative Commons License. |
spellingShingle | Brief Report Reber, Stefan Mechtersheimer, Jonas Nasif, Sofia Benitez, Julio Aguila Colombo, Martino Domanski, Michal Jutzi, Daniel Hedlund, Eva Ruepp, Marc-David CRISPR-Trap: a clean approach for the generation of gene knockouts and gene replacements in human cells |
title | CRISPR-Trap: a clean approach for the generation of gene knockouts and gene replacements in human cells |
title_full | CRISPR-Trap: a clean approach for the generation of gene knockouts and gene replacements in human cells |
title_fullStr | CRISPR-Trap: a clean approach for the generation of gene knockouts and gene replacements in human cells |
title_full_unstemmed | CRISPR-Trap: a clean approach for the generation of gene knockouts and gene replacements in human cells |
title_short | CRISPR-Trap: a clean approach for the generation of gene knockouts and gene replacements in human cells |
title_sort | crispr-trap: a clean approach for the generation of gene knockouts and gene replacements in human cells |
topic | Brief Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5909934/ https://www.ncbi.nlm.nih.gov/pubmed/29167381 http://dx.doi.org/10.1091/mbc.E17-05-0288 |
work_keys_str_mv | AT reberstefan crisprtrapacleanapproachforthegenerationofgeneknockoutsandgenereplacementsinhumancells AT mechtersheimerjonas crisprtrapacleanapproachforthegenerationofgeneknockoutsandgenereplacementsinhumancells AT nasifsofia crisprtrapacleanapproachforthegenerationofgeneknockoutsandgenereplacementsinhumancells AT benitezjulioaguila crisprtrapacleanapproachforthegenerationofgeneknockoutsandgenereplacementsinhumancells AT colombomartino crisprtrapacleanapproachforthegenerationofgeneknockoutsandgenereplacementsinhumancells AT domanskimichal crisprtrapacleanapproachforthegenerationofgeneknockoutsandgenereplacementsinhumancells AT jutzidaniel crisprtrapacleanapproachforthegenerationofgeneknockoutsandgenereplacementsinhumancells AT hedlundeva crisprtrapacleanapproachforthegenerationofgeneknockoutsandgenereplacementsinhumancells AT rueppmarcdavid crisprtrapacleanapproachforthegenerationofgeneknockoutsandgenereplacementsinhumancells |